Oxyphenbutazone
A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
Also Known As:
Belmac Brand of Oxyphenbutazone; Diflamil; Novartis Ophthalmics Brand of Oxyphenbutazone; Oxyphenylbutazone; Tanderil; Hydroxyphenylbutazone; 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-
Networked: 198
relevant articles (6 outcomes,
19 trials/studies)
Relationship Network
Drug Context: Research Results
Experts
1. | Bodaghi, Bahram:
1 article
(04/2011)
|
2. | Sharma, Om P:
1 article
(04/2011)
|
3. | Murray, Philip I:
1 article
(04/2011)
|
4. | Tokuda, Harukuni:
1 article
(04/2010)
|
5. | Azuine, Magnus A:
1 article
(04/2010)
|
6. | Shigeta, Yuuko:
1 article
(04/2010)
|
7. | Kapadia, Govind J:
1 article
(04/2010)
|
8. | Suzuki, Nobutaka:
1 article
(04/2010)
|
9. | Tigka, E:
1 article
(10/2005)
|
10. | Tesseromatis, C:
1 article
(10/2005)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures